Contact Information for physicians/patients
Clinic for Children and Adolescent Medicine:
Contact: Victoria.Schwarzmayr(at)uk-erlangen.de
Particular rare liver disease expertise of the centre
AIH, ASC, PSC, SSC, PBC, neonatal and adult cholestasis syndromes, A1AT deficiency as well as inborn and acquired metabolic diseases affecting the liver. Our University Hospital also offers the participation in various clinical trials regarding novel therapeutic interventions regarding these rare liver diseases.
Covered Liver Diseases in the ERN spectrum:- Primary Biliary Cholangitis (PBC)
- Autoimmune Hepatitis (AIH)
- Primary Sclerosing Cholangitis (PSC)
- IgG4-related Liver Disease
- Genetic Cholestatic Disease
- Biliary Atresia
- Alpha-1-Antitrypsin Deficiency (A1ATD)
- Wilson Disease
- Intrahepatic Cholangiocarcinoma (iCCA)
- Acute Liver Failure
- Liver disease in pregnancy
ERN Representatives
-
Priv.Doz. Peter Dietrich (MD, PhD)
Hepatologist, Specialist for Liver Tumors
-
Priv. Doz. André Hörning (MD)
Pediatric Gastroenterologist/Hepatologist, Specialist for Immunology
ERN Team and Contact
Clinic for Children and Adolescent Medicine:
Contact:
andre.hoerning(at)uk-erlangen.de
Clinic for Medicine 1:
Contact:
peter.dietrich(at)uk-erlangen.de
andreas.kremer(at)usz.ch
Centre information
The ERN Rare-Liver core unit at the University Hospital Erlangen is on the highest State-of-the-Art level regarding diagnostic and therapeutic expertise and technology. The participating physicians are also active members of the German Center of Immuntherapy (DZI).
The center offers a high level of team cooperation and interaction as well as a multidisciplinary approach to treat difficult and unique cases, offering the highest standards of medical care for rare liver diseases such as autoimmune hepatitis (AIH), autoimmune sclerosing cholangitis (ASC) primary and secondary sclerosing cholangitis (PSC, SSC), primary biliary cholangitis (PBC), neonatal and adult cholestasis syndromes including Alagille syndrome, biliary atresia, biliary malformations and genetic cholestatic diseases such as benign recurrent intrahepatic cholestasis (BRIC) and progressive familial intrahepatic cholestasis (PFIC), A1AT deficiency, Wilson Disease, Hemochromatosis, Polycystic Liver Disease, Rare Liver Tumours of children and adults, Acute Liver Failure (ALF), as well as inborn and acquired metabolic diseases. affecting the liver. We also focus on participation to national and international treatment guidelines and on the registration of different aspects of quality of life including pruritus etc. Moreover, we treat pregnancy related hepatobiliary disorders such as such as intrahepatic cholestasis of pregnancy (ICP), HELLP syndrome, PE, acute fatty liver of pregnancy (AFLD) according to state-of-the-art procedures.